Pfizer Halts Development of Once-Daily Obesity Pill After Safety Concerns
"Tough break for those hoping for a pill solution to obesity!"
"Is there any insight on what the next steps for Pfizer will be?"
"I wonder how this will affect the obesity drug market overall."
"I can't believe they had to stop testing again. So frustrating!"
"Interesting to see how the market responds to this news."
"Anyone else surprised by the safety issues with danuglipron?"
"Why is it so hard to get these weight-loss drugs covered by insurance?"
"Injectables are so inconvenient; I really hope they find a suitable pill soon."
"Pfizer needs to step it upthey can't afford many more delays!"
"At this rate, I might just stick to diet and exercise."
"I guess this means well just have to wait longer for an oral option."
2025-04-14T14:24:52Z
Aaliyah Carter
Source of the news: Time